Scarica l'app Stockscreener
2.57
2.65%
-0.07
Dopo l'orario di chiusura:
2.55
-0.02
-0.78%
Precedente Chiudi:
$2.64
Aprire:
$2.61
Volume 24 ore:
86,002
Relative Volume:
0.51
Capitalizzazione di mercato:
$18.15M
Reddito:
$2.90M
Utile/perdita netta:
$87.91M
Rapporto P/E:
0.1646
EPS:
15.6103
Flusso di cassa netto:
$-26.93M
1 W Prestazione:
-5.17%
1M Prestazione:
+38.92%
6M Prestazione:
+77.24%
1 anno Prestazione:
-49.01%
Intervallo 1D:
$2.52
$2.74
Intervallo di 1 settimana:
$2.47
$3.10
Portata 52W:
$0.97
$19.44
Traws Pharma Inc Stock (TRAW) Company Profile
Nome
Traws Pharma Inc
Settore
Industria
Telefono
267-759-3680
Indirizzo
12 PENNS TRAIL, NEWTOWN
Confronta TRAW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
2.57 | 18.81M | 2.90M | 87.91M | -26.93M | 15.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-03-01 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-05-18 | Iniziato | Guggenheim | Buy |
| 2018-03-01 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-17 | Downgrade | Maxim Group | Buy → Hold |
| 2017-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2017-04-27 | Iniziato | Laidlaw | Buy |
| 2015-07-01 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2015-05-05 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Traws Pharma Inc Borsa (TRAW) Ultime notizie
What the charts say about Traws Pharma Inc. todayExit Point & Stepwise Trade Signal Guides - newser.com
Using RSI to spot recovery in Traws Pharma Inc.2025 Top Decliners & Weekly Top Gainers Alerts - newser.com
Is Traws Pharma Inc. (0T20) stock supported by free cash flowJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
Is Traws Pharma Inc. (0T20) stock testing key supportJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - newser.com
Live market analysis of Traws Pharma Inc.2025 Support & Resistance & Advanced Technical Signal Analysis - newser.com
Visualizing Traws Pharma Inc. stock with heatmapsJuly 2025 Action & Weekly High Potential Alerts - newser.com
What technical models suggest about Traws Pharma Inc.’s comebackEarnings Growth Report & Risk Controlled Daily Plans - newser.com
Will Traws Pharma Inc. (0T20) stock extend growth storyJuly 2025 Fed Impact & Consistent Profit Alerts - newser.com
Price action breakdown for Traws Pharma Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com
Is Traws Pharma Inc. forming a reversal patternMarket Activity Report & High Accuracy Investment Signals - newser.com
Traws Pharma (NASDAQ:TRAW) Upgraded at Wall Street Zen - Defense World
Tick level data insight on Traws Pharma Inc. volatilityPortfolio Gains Summary & Breakout Confirmation Alerts - newser.com
Technical signs of recovery in Traws Pharma Inc.July 2025 Summary & Accurate Technical Buy Alerts - newser.com
Is a relief rally coming for Traws Pharma Inc. holdersWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials - MarketScreener
2025-10-30 | ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials | NDAQ:TRAW | Press Release - Stockhouse
Advanced analytics toolkit walkthrough for Traws Pharma Inc.Earnings Risk Report & Fast Gain Stock Tips - newser.com
Measuring Traws Pharma Inc.’s beta against major indicesWeekly Risk Report & High Yield Equity Trading Tips - newser.com
How Traws Pharma Inc. stock reacts to inflationary pressuresWeekly Trade Report & Verified Technical Trade Signals - newser.com
Traws Pharma’s New COVID-19 Drug Trial: A Potential Game-Changer? - TipRanks
Traws Pharma’s TRX-100 Study: A Potential Game-Changer in Pharmacokinetics - TipRanks
Traws Pharma Inc Azioni (TRAW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):